10X GENOMICS INC-CLASS A (TXG) Institutional Buying Activity

Institutional investors tracked by InsiderSet increased exposure to 10X GENOMICS INC-CLASS A (TXG) during the quarter ended March 31, 2026 through a combination of new purchases and expanded existing positions disclosed in SEC Form 13F filings.

The largest institutional buyer of TXG during the latest reporting period was ARK Invest, which increased its reported TXG position by approximately $84.16M based on quarter-end filing values. Several additional hedge funds and long-term asset managers also reported meaningful increases in TXG exposure during the quarter.

Institutional buying activity can provide insight into investor conviction, sector allocation trends, and smart money positioning toward 10X GENOMICS INC-CLASS A (TXG). InsiderSet tracks quarterly accumulation trends, new institutional positions, ownership increases, and estimated performance of newly disclosed holdings using SEC filing data and recent market prices.

The investors highlighted on this page collectively added approximately $310.50M in reported TXG exposure during the latest filing period, reflecting continued institutional interest in 10X GENOMICS INC-CLASS A's growth initiatives and strategic positioning.

Portfolio quarterNameTypeQuantityRemainingReported stock balance
Q4 2025ARK InvestBuy779,97312,667,369$206,604,788
Q4 2025Renaissance Technologies LLCBuy505,6181,550,539$25,289,291
Q2 2025ARK InvestBuy1,046,39013,892,103$160,870,554
Q2 2025Renaissance Technologies LLCBuy782,7001,472,255$17,048,713
Q1 2025ARK InvestBuy901,65612,845,713$112,143,078
Q1 2025Renaissance Technologies LLCBuy302,600689,555$6,019,815
Q4 2024ARK InvestBuy1,193,71211,944,057$171,516,651
Q4 2024Renaissance Technologies LLCBuy176,755386,955$5,556,674
Q3 2024ARK InvestBuy1,436,58210,750,345$242,742,797
Q2 2024ARK InvestBuy3,029,9519,313,763$181,152,698
Q2 2024Renaissance Technologies LLCBuy157,800210,200$4,088,390
Q1 2024ARK InvestBuy2,242,5256,283,812$235,831,466
Q4 2023ARK InvestBuy1,047,8274,041,287$226,150,446
Q3 2022ARK InvestBuy973,5284,576,814$130,348
Q2 2022ARK InvestBuy211,9483,603,286$184,452
Q1 2022ARK InvestBuy730,4723,391,338$257,979
Q1 2022Renaissance Technologies LLCBuy40,00057,800$4,397
Q2 2021ARK InvestBuy795,9164,300,037$842,033
Q1 2021ARK InvestBuy2,970,6253,504,121$634,246
Q1 2021Parnassus Endeavor FundBuy21,51193,160$16,862
Q4 2020ARK InvestBuy302,399533,496$75,543
Q4 2020Parnassus Endeavor FundBuy71,64971,649$10,145
Q3 2020Third PointBuy123,268123,268$15,369
Q3 2020Renaissance Technologies LLCBuy6,464296,100$36,918
Q2 2020ARK InvestBuy336,553336,553$30,058
Q2 2020Renaissance Technologies LLCBuy279,100289,636$25,867
Q1 2020Renaissance Technologies LLCBuy10,53610,536$657
Q3 2019Viking Global InvestorsBuy71,06971,069$3,582

Frequently asked questions about TXG activity

  • Which institutional owners are buying TXG?

    Institutional owners buying TXG include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.

  • What does "buy" mean in TXG activity?

    "Buy" means an investor increased their reported position in TXG compared to the prior reporting period. This reflects growing exposure to 10X GENOMICS INC-CLASS A (TXG) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).

  • Is institutional interest in TXG increasing?

    Institutional interest in TXG can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.

Related Buying Insights